Inferior vena cava (IVC) filters are widely used in patients who cannot take blood thinners. The IVC is the largest vein in the body, running from the legs to the chest. IVC filters keep blood clots ...

Despite clinical trial data showing inferior vena cava (IVC) filters are ineffective for reducing mortality following deep vein thrombosis (DVT), as well as guideline recommendations against their use ...

The treatment of choice for proximal venous thrombosis is anticoagulation. In situations where anticoagulation is absolutely contraindicated or when anticoagulation has failed in the face of an acute ...

Inferior vena cava filters have emerged as a popular tool to reduce risk for pulmonary embolism. Nevertheless, their use can be a polarizing issue among physicians. “Many physicians would say that ...

CDRH says it is requiring collection of additional clinical data for currently marketed inferior vena cava (IVC) filters to address safety questions that remain unanswered for both permanent and ...

A new study suggests that retrievable inferior vena cava filters do not further improve outcomes in patients with severe acute pulmonary embolism who receive anticoagulation therapy. Specifically, the ...

(UPDATED) Laser sheaths can safely and successfully enable retrieval of chronic indwelling inferior vena cava (IVC) filters, according to data on 500 people from a long-running, first-in-human study.

(HealthDay)—The rates of inferior vena cava (IVC) filter placement increased from 2005 until 2010 and then decreased through 2014, according to a research letter published online Nov. 6 in JAMA ...

Please provide your email address to receive an email when new articles are posted on . Inferior vena cava filters have become an increasingly popular tool to reduce risk for recurrent pulmonary ...

BLOOMINGTON, Ind.--(BUSINESS WIRE)--On January 6, Cook announced that the United States District Court for the Southern District of Indiana vacated in its entirety a February 1, 2019, judgment against ...

Two medical device companies that were hit last month with a $33 million verdict over their allegedly defective blood filter devices are seeking to have the award overturned. Rex Medical and Argon ...